Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma

Fig. 3

(A): Surviving fraction (SF) of U251 cells irradiated with 2–8 Gy and treated with xenon (Xe), memantine (Mem) or both (Xe + Mem). Error bars indicate 95% confidence interval. Significant reduction in SF was found for Mem or Xe starting at a dose of 4 Gy and for Xe + Mem starting at 2 Gy (*t-test p < 0.05). (B): Linear-quadratic regression analysis. Error bars indicate standard error of mean. Data are given as means of at least three independent experiments and were normalised to plating efficiency. Non-normalised data are shown in the appendix (Supplementary Fig. 3)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us